Gavin Cloherty

4.2k total citations
179 papers, 2.2k citations indexed

About

Gavin Cloherty is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Gavin Cloherty has authored 179 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Epidemiology, 101 papers in Hepatology and 73 papers in Infectious Diseases. Recurrent topics in Gavin Cloherty's work include Hepatitis C virus research (99 papers), Hepatitis B Virus Studies (96 papers) and Liver Disease Diagnosis and Treatment (58 papers). Gavin Cloherty is often cited by papers focused on Hepatitis C virus research (99 papers), Hepatitis B Virus Studies (96 papers) and Liver Disease Diagnosis and Treatment (58 papers). Gavin Cloherty collaborates with scholars based in United States, Germany and Canada. Gavin Cloherty's co-authors include Mary C. Kuhns, Jeffrey Gersch, Vera Holzmayer, Mary A. Rodgers, Michael G. Berg, Christoph Sarrazin, Ka‐Cheung Luk, Anne L. McNamara, Mark Anderson and Heiner Wedemeyer and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Gavin Cloherty

164 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gavin Cloherty United States 25 1.4k 1.3k 785 293 200 179 2.2k
Nico Lelie Netherlands 31 2.1k 1.5× 1.9k 1.4× 696 0.9× 256 0.9× 191 1.0× 54 2.7k
Paul R. Grant United Kingdom 24 759 0.5× 535 0.4× 542 0.7× 238 0.8× 350 1.8× 45 1.7k
Anna Rosa Garbuglia Italy 21 1.0k 0.7× 753 0.6× 751 1.0× 665 2.3× 506 2.5× 120 2.1k
Cristina Giachetti United States 26 1.0k 0.7× 579 0.4× 531 0.7× 250 0.9× 392 2.0× 43 1.8k
Bianca Bruzzone Italy 23 850 0.6× 471 0.4× 948 1.2× 424 1.4× 202 1.0× 120 1.8k
Lia Laura Lewis‐Ximenez Brazil 26 1.3k 0.9× 1.7k 1.3× 768 1.0× 228 0.8× 153 0.8× 101 2.4k
Monica M. Parker United States 21 692 0.5× 302 0.2× 1.1k 1.4× 351 1.2× 235 1.2× 53 1.7k
Antonio Rivero‐Juárez Spain 23 754 0.5× 1.5k 1.1× 919 1.2× 95 0.3× 50 0.3× 172 1.9k
Angeline Bartholomeusz Australia 34 3.7k 2.6× 3.5k 2.7× 1.1k 1.4× 157 0.5× 132 0.7× 53 4.0k
Carla Osiowy Canada 24 1.5k 1.1× 1.3k 1.0× 602 0.8× 46 0.2× 129 0.6× 97 2.0k

Countries citing papers authored by Gavin Cloherty

Since Specialization
Citations

This map shows the geographic impact of Gavin Cloherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Cloherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Cloherty more than expected).

Fields of papers citing papers by Gavin Cloherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Cloherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Cloherty. The network helps show where Gavin Cloherty may publish in the future.

Co-authorship network of co-authors of Gavin Cloherty

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Cloherty. A scholar is included among the top collaborators of Gavin Cloherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Cloherty. Gavin Cloherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferreira, Noely Evangelista, Michael G. Berg, Antônio Charlys da Costa, et al.. (2025). Metagenomic detection of central nervous system infections missedby conventional testing. JCI Insight. 10(13). 1 indexed citations
2.
Yamaguchi, Julie, Gregory S. Orf, Lester J. Pérez, et al.. (2025). First Evidence of Spillover of Rocahepevirus ratti Into Humans in Thailand. Transboundary and Emerging Diseases. 2025(1). 9954682–9954682.
3.
Anderson, Mark, Gavin Cloherty, Hyon S. Hwang, et al.. (2025). Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment. Journal of Clinical Investigation. 135(6). 1 indexed citations
4.
Anderson, Mark, Ana Vallari, Barbara J. Harris, et al.. (2025). Detection of diverse HIV strains by the m-PIMATM HIV-1/2 detect point-of-care assay. Journal of Clinical Virology. 177. 105771–105771.
5.
6.
Janjua, Naveed Z., et al.. (2024). Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population. Journal of Viral Hepatitis. 31(6). 320–323. 1 indexed citations
7.
Iqbal, Hussain Syed, Mark G. Anderson, Allison M. McFall, et al.. (2024). Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional Study. Open Forum Infectious Diseases. 11(7). ofae350–ofae350.
8.
Bbosa, Nicholas, Vera Holzmayer, Deogratius Ssemwanga, et al.. (2024). Sequence Notes: Near Full-Length Genome Analysis of the First-Reported HIV-1 Circulating Recombinant Form (CRF)_10CD in Uganda. AIDS Research and Human Retroviruses. 40(12). 718–721.
9.
Cotler, Scott J., Louis Shekhtman, Michel Bazinet, et al.. (2024). HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure. Antiviral Research. 234. 106061–106061. 3 indexed citations
10.
11.
Mak, Lung‐Yi, Gavin Cloherty, Danny Ka‐Ho Wong, et al.. (2020). HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy. Hepatology. 73(6). 2167–2179. 56 indexed citations
12.
Seto, Wai‐Kay, Lung‐Yi Mak, Gavin Cloherty, et al.. (2020). Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation. Gut. 70(4). 775–783. 57 indexed citations
13.
Orner, Erika P., Mary A. Rodgers, Karl Hock, et al.. (2020). Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities. Diagnostic Microbiology and Infectious Disease. 99(4). 115300–115300. 24 indexed citations
14.
Junqueira, Dennis Maletich, Eduan Wilkinson, Ana Vallari, et al.. (2020). New Genomes from the Congo Basin Expand History of CRF01_AE Origin and Dissemination. AIDS Research and Human Retroviruses. 36(7). 574–582. 6 indexed citations
15.
Kuhns, Mary C., Anne L. McNamara, Vera Holzmayer, & Gavin Cloherty. (2019). Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors. Virology Journal. 16(1). 43–43. 11 indexed citations
16.
Catlett, Beth, F. Lamoury, Sahar Bajis, et al.. (2019). Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Journal of Viral Hepatitis. 26(12). 1423–1430. 13 indexed citations
17.
18.
Locarnini, Stephen, Bruce D. Given, Thomas Schluep, et al.. (2019). First clinical experience with RNA interference [RNAI]-based triple combination therapy in chronic hepatitis B (CHB): JNJ-73763989 (JNJ-3989), JNJ-56136379 (JNJ-6379) and a nucleos(t)ide analogue (NA). Hepatology. 70(6). 7 indexed citations
19.
Lamoury, F., Behzad Hajarizadeh, Camelia Quek, et al.. (2018). Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples. Journal of Molecular Diagnostics. 20(5). 621–627. 19 indexed citations
20.
Rodgers, Mary A., Ana Vallari, Julie Yamaguchi, et al.. (2017). ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens. AIDS Research and Human Retroviruses. 34(3). 314–318. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nico Lelie Breakdown of academic impact, for papers by Paul R. Grant Breakdown of academic impact, for papers by Anna Rosa Garbuglia Breakdown of academic impact, for papers by Cristina Giachetti Breakdown of academic impact, for papers by Bianca Bruzzone Breakdown of academic impact, for papers by Lia Laura Lewis‐Ximenez Breakdown of academic impact, for papers by Monica M. Parker Breakdown of academic impact, for papers by Antonio Rivero‐Juárez Breakdown of academic impact, for papers by Angeline Bartholomeusz Breakdown of academic impact, for papers by Carla Osiowy
Rankless by CCL
2026